INVESTED: High-Dose vs Standard-Dose Influenza Vaccine in High-Risk Cardiovascular Disease Patients

November 13-17, 2020; Virtual Conference
High-dose trivalent influenza vaccine was comparable to standard-dose quadrivalent vaccine regarding deaths or cardiopulmonary hospitalizations.
Format: Microsoft PowerPoint (.ppt)
File Size: 217 KB
Released: November 20, 2020

Acknowledgements

Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Merck

Related Content

Vericiguat VICTORIA subgroup analysis from AHA, as reported by CCO

Released: November 18, 2020

Ferric carboxymaltose reduced risk of subsequent hospitalization in iron-deficient acute heart failure: AFFIRM-AHF data from AHA 2020, by CCO

Released: November 18, 2020

Omecamtiv mecarbil reduced time to first heart failure event or cardiovascular death in patients with heart failure with reduced ejection fraction: GALACTIC-HF data from AHA 2020 as reported by CCO

Released: November 16, 2020

Downloadable PDF resource with expert answers to FAQ on heart failure.

person default Margaret Bowers, DNP, FNP-BC person default Gregg C. Fonarow, MD person default Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, FASCP, FAzPA Released: July 24, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue